Dirk STENKAMP

CGRP antagonists

3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents

Inhibitors of the microsomal prostaglandin E2 synthase-1

NOUVEL COMPOUNDS

1H-benzimidazole-5-carboxamides as anti-inflammatory agents

1H-benz imidazole-5-carboxamides as anti-inflammatory agents

Compounds

Compounds

CGRP antagonists

CGRP ANTAGONISTS

SELECTED CGRP ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

Compounds

Compounds

NEW COMPOUNDS

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds

CGRP Antagonists

New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions

Use of aminoalcohol derivatives for the treatment of overactive bladder

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions

Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds

Use of selected CGRP antagonists for combating menopausal hot flushes

Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine

Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Use of selected CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients

CGRP antagonists

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Compounds and compositions for treating obesity

New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Beta-agonists, processes for preparing them and their use as pharmaceutical compositions

Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients

Use of selected CGRP antagonists for combating menopausal hot flushes

Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Amide compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

β-ketoamide compounds with MCH antagonistic activity

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Substituted imidazoles, their preparation and use